Diabetes drug shows promise for weight loss in new study
NCT ID NCT07367555
First seen Feb 01, 2026 · Last updated May 05, 2026 · Updated 9 times
Summary
This study tested whether a common diabetes drug (SGLT-2 inhibitor) can help people with type 2 diabetes lose weight. 360 adults took the drug for 3 months, and their body mass index (BMI) was measured before and after. The goal was to see if the drug could help control weight, which is important for managing diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMH Multan
Multan, Punjab Province, 60010, Pakistan
Conditions
Explore the condition pages connected to this study.